KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Gross Margin (2016 - 2025)

Historic Gross Margin for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to 49.8%.

  • Bio-Rad Laboratories' Gross Margin fell 14400.0% to 49.8% in Q4 2025 from the same period last year, while for Dec 2025 it was 51.87%, marking a year-over-year decrease of 18600.0%. This contributed to the annual value of 51.87% for FY2025, which is 18600.0% down from last year.
  • Bio-Rad Laboratories' Gross Margin amounted to 49.8% in Q4 2025, which was down 14400.0% from 52.59% recorded in Q3 2025.
  • Bio-Rad Laboratories' 5-year Gross Margin high stood at 58.43% for Q3 2021, and its period low was 49.8% during Q4 2025.
  • For the 5-year period, Bio-Rad Laboratories' Gross Margin averaged around 54.21%, with its median value being 54.07% (2022).
  • In the last 5 years, Bio-Rad Laboratories' Gross Margin soared by 24000bps in 2022 and then tumbled by -39600bps in 2023.
  • Over the past 5 years, Bio-Rad Laboratories' Gross Margin (Quarter) stood at 54.57% in 2021, then dropped by 0bps to 54.37% in 2022, then decreased by -1bps to 53.77% in 2023, then decreased by -5bps to 51.24% in 2024, then dropped by -3bps to 49.8% in 2025.
  • Its Gross Margin was 49.8% in Q4 2025, compared to 52.59% in Q3 2025 and 52.99% in Q2 2025.